KeyBank National Association’s Anixa Biosciences ANIX Stock Holding History

KeyBank National Association’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$40.8K	Hold	15,810	–	–	﹤0.01%	1233
2025 Q4	$49.3K	Buy	15,810 +300	+2%	+$1.23K	﹤0.01%	1191
2025 Q3	$51.2K	Hold	15,510	–	–	﹤0.01%	1172
2025 Q2	$51.2K	Hold	15,510	–	–	﹤0.01%	1158
2025 Q1	$44.4K	Hold	15,510	–	–	﹤0.01%	1143
2024 Q4	$36K	Hold	15,510	–	–	﹤0.01%	1151
2024 Q3	$48.9K	Hold	15,510	–	–	﹤0.01%	1125
2024 Q2	$34.3K	Hold	15,510	–	–	﹤0.01%	1085
2024 Q1	$48.4K	Hold	15,510	–	–	﹤0.01%	1078
2023 Q4	$60.2K	Hold	15,510	–	–	﹤0.01%	1066
2023 Q3	$50.7K	Hold	15,510	–	–	﹤0.01%	1019
2023 Q2	$49.6K	Hold	15,510	–	–	﹤0.01%	1045
2023 Q1	$66.7K	Hold	15,510	–	–	﹤0.01%	1040
2022 Q4	$65.9K	Hold	15,510	–	–	﹤0.01%	1039
2022 Q3	$76K	Hold	15,510	–	–	﹤0.01%	1021
2022 Q2	$47K	Hold	15,510	–	–	﹤0.01%	1051
2022 Q1	$42K	Buy	+15,510	New	+$45.5K	﹤0.01%	1063

Other funds holding ANIX

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LNWTC

Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

KeyBank National Association's ANIX Position: Q1 2026 in Review

KeyBank National Association held its Anixa Biosciences (ANIX) position steady in Q1 2026 at 15,810 shares worth $40.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1233.

KeyBank National Association first reported a position in ANIX in Q1 2022 and has held it in 17 quarters since. The position peaked at $76K in Q3 2022. 60 funds tracked by Wall St. Rank hold ANIX as of Q1 2026.

KeyBank National Association held 15,810 shares of Anixa Biosciences worth $40.8K as of Q1 2026.
KeyBank National Association left its Anixa Biosciences share count unchanged in Q1 2026.
Anixa Biosciences made up ﹤0.01% of KeyBank National Association's portfolio in Q1 2026, its #1233 holding.
KeyBank National Association first reported a position in Anixa Biosciences in Q1 2022 and has held it in 17 quarters since.
KeyBank National Association's Anixa Biosciences position peaked at $76K in Q3 2022.
60 funds tracked by Wall St. Rank held Anixa Biosciences as of Q1 2026.

Based on KeyBank National Association's 13F filing for Q1 2026, filed 24 Apr 2026.